When mRNA (messenger RNA) vaccines are injected into a patient, tiny lipid vesicles transport mRNA molecules through the body fluids and merge with immune cells, called antigen-presenting cells (APCs). mRNA vaccines work to instruct APCs to manufacture proteins called antigens that evoke an immune response to the threat.
Related CAS Insights
Drug Discovery
A review of the global efforts on COVID-19 vaccine development
March 29, 2021
Read article
Drug Discovery
ACE2: Targeting a potentially important receptor in disease pathogenesis
December 15, 2022
Read article
Drug Discovery
ACS webinar on molecular glues and targeted protein degradation
October 12, 2022
Read articleGain new perspectives for faster progress directly to your inbox.
